BRIEF published on 11/07/2024 at 11:53, 14 days 2 hours ago ELARIS AG Appoints Steffen Cost as Chief Commercial Officer to Foster Growth Automotive Industry International Growth E-mobility ELARIS AG Steffen Cost
PRESS RELEASE published on 11/07/2024 at 11:48, 14 days 2 hours ago ELARIS AG strengthens internal structures to enable further growth / Steffen Cost named Chief Commercial Officer (CCO) ELARIS AG appoints Steffen Cost as Chief Commercial Officer to strengthen internal structures for international growth Chief Commercial Officer International Growth ELARIS AG Steffen Cost Internal Structures
BRIEF published on 10/10/2024 at 09:35, 1 month 11 days ago ELARIS AG Considers Offshoring to Counter EU Tariffs Electric Cars ELARIS AG Offshoring EU Tariffs SKD Production
PRESS RELEASE published on 10/10/2024 at 09:30, 1 month 11 days ago ELARIS AG is considering the possibility of offshoring SKD production in response to the threat of punitive EU tariffs ELARIS AG considers offshoring SKD production to avoid EU tariffs on Chinese e-cars, in talks with potential partners from three countries ELARIS AG Offshoring EU Tariffs SKD Production E-cars
BRIEF published on 09/24/2024 at 10:35, 1 month 27 days ago ELARIS AG: Kiesel Group's Investment Opens Up Strategic Business Potential Innovation Construction Industry Electric Vehicles Strategic Partnership Investment
PRESS RELEASE published on 09/24/2024 at 10:30, 1 month 27 days ago ELARIS AG: Kiesel Group's investment opens up strategic business potential ELARIS AG's partnership with Kiesel Group aims to boost strategic business opportunities in electrification of construction vehicles, supported by Kiesel's expertise and investment Electrification Investment ELARIS AG Kiesel Group Strategic Business Potential
BRIEF published on 09/17/2024 at 09:19, 2 months 4 days ago ELARIS AG Achieves First Positive Operating Result in H1 2024 Revenue Growth Electric Vehicles Operating Profit ELARIS 2024 Results
PRESS RELEASE published on 09/17/2024 at 09:14, 2 months 4 days ago ELARIS AG posts its first positive operating result in the first half of 2024 and grows dynamically ELARIS AG achieves its first positive operating result in the first half of 2024, with sales revenues growing dynamically and significant further growth expected for the full year 2024 Growth ELARIS AG Sales Revenues Positive Operating Result
BRIEF published on 08/23/2024 at 18:25, 2 months 28 days ago ELARIS AG: Annual General Meeting Approves All Agenda Items with a Clear Majority Growth Strategy Annual General Meeting Shareholders International Expansion ELARIS AG
PRESS RELEASE published on 08/23/2024 at 18:20, 2 months 28 days ago ELARIS AG: Annual General Meeting approves all agenda items with a clear majority ELARIS AG shareholders approve all agenda items with a 97.6% majority at Annual General Meeting, focusing on growth strategy and international expansion Growth Strategy Annual General Meeting International Expansion ELARIS AG Agenda Items
Published on 11/21/2024 at 14:00, 10 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 13:30, 40 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 40 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 12:35, 1 hour 35 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 55 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 12 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 50 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo